CD40LG and hepatocellular carcinoma: Squamous Cell Carcinoma Antigen (SCCA) and SCCA-IgM complexes have also emerged as potential markers, with SCCA-IgM showing greater sensitivity and specificity in prognosticating HCC response to therapy.